Risk factors for oxygen requirement in hospitalized pregnant and postpartum women with COVID-19

被引:1
|
作者
Baptista, Fernanda Spadotto [1 ]
Paganoti, Cristiane Freitas [2 ]
Gomez, Ursula Trovato [1 ]
Peres, Stela Verzinhasse [2 ]
Malbouisson, Luiz Marcelo [3 ]
Brizot, Maria de Lourdes [3 ]
Vieira Francisco, Rossana Pulcineli [3 ]
机构
[1] Univ Sao Paulo FMUSP, Fac Med, Dept Obstet & Ginecol, Disciplina Obstet, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo HCFMUSP, Hosp Clin, Fac Med, Div Clin Obstet, Sao Paulo, SP, Brazil
[3] Univ Sao Paulo FMUSP, Fac Med, Dept Cirurgia, Disciplina Anestesiol, Sao Paulo, SP, Brazil
来源
CLINICS | 2022年 / 77卷
关键词
COVID-19; Risk factors; Pregnancy; Maternal mortality; Oxygen supply; Intensive care unit; Severe acute respiratory syndrome; PNEUMONIA; COHORT; DEATH;
D O I
10.1016/j.clinsp.2022.100072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify risk factors for Oxygen (O-2) needs in pregnant and postpartum women with COVID-19. Methods: Prospective cohort involving pregnant women hospitalized with COVID-19 from April to October 2020. The oxygen need was analyzed regarding risk factors: demographic characteristics, clinical and laboratory parameters at hospital admission, and chest Computer Tomography (CT) findings. Poisson univariate analysis was used to estimate the Relative Risk (RR) and 95% Confidence Intervals. Results: 145 patients, 80 who used and 65 who did not use O-2, were included. Body mass index >= 30, smoking, and chronic hypertension increased the risk of O-2 need by 1.86 (95% CI 1.10-3.21), 1.57 (95% CI 1.16-2.12), and 1.46 (95% CI 1.09-1.95), respectively. Patients who were hospitalized for COVID-19 and for obstetric reasons had 8.24 (95% CI 2.8-24.29) and 3.44 (95% CI 1.05-11.31) times more use of O-2 than those admitted for childbirth and abortion. Respiratory rate >= 24 breaths/min and O-2 saturation < 95% presented RR for O-2 requirements of 2.55 (1.82-3.56) and 1.68 (95% CI 1.27-2.20), respectively. Ground Glass (GG) < 50% and with GG >= 50%, the risk of O-2 use were respectively 3.41-fold and 5.33-fold higher than in patients who haven't viral pneumonia on CT. The combination of C-reactive protein >= 21 mg/L, hemoglobin < 11.0 g/dL, and lymphopenia < 1500 mm(3) on hospital admission increased the risk of O-2 use by 4.97-times. Conclusions: In obstetric patients, clinical history, laboratory, clinical and radiological parameters at admission were identified as a risk for O-2 need, selecting the population with the greatest chance of worsening.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Risk Factors for COVID-19 Cluster Infection in Hospitalized Patients
    Sakoda, Yoritake
    Matsumoto, Takanori
    Yamaguchi, Masaki
    Kudo, Asuka
    Nakano, Kumiko
    Maeno, Yasuki
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [42] Risk Factors of Ftal Outcome of Hospitalized Patients with COVID-19
    Wu, Weihua
    Zhang, Xulei
    Chen, Yuxin
    Wang, Baofeng
    Wu, Jing
    Xiong, Yali
    Jia, Bei
    Wang, Jian
    Xia, Juan
    Pu, Yangjuan
    Zhou, Wensan
    Chen, Zhong
    Zhang, Zhaoping
    Yan, Xiaomin
    Huang, Rui
    Wu, Chao
    [J]. DISCOVERY MEDICINE, 2021, 31 (164) : 121 - 127
  • [43] Incidence and risk factors of myocarditis in hospitalized patients with COVID-19
    Keller, Karsten
    Sagoschen, Ingo
    Konstantinides, Stavros
    Gori, Tommaso
    Muenzel, Thomas
    Hobohm, Lukas
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (03)
  • [44] Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
    Limachi-Choque, Jhonny
    Guitian, Javier
    Leyns, Christine
    Guzman-Rivero, Miguel
    Eid, Daniel
    [J]. IJID REGIONS, 2023, 9 : 95 - 101
  • [45] Risk and Protective Factors for COVID-19 Infection Among Pregnant Women with Sickle Cell Trait
    Aldecoa, Kim Abbegail Tan
    Arsene, Camelia
    Chng, Tiffany
    Cherry, Garett
    Chowdhury, Nabila
    Clark, Ryan
    Deeb, Dana
    Deptula, Lisa
    Dietz, Grey
    Eto, Ewomamobuho
    Golston, Victoria
    Lawson, Landon
    Mbionwu, Chioma
    Okponyia, Obiefuna
    Orejuela, Jennifer
    Qipo, Thomaida
    Raut, Sumit
    Krishnamoorthy, Geetha
    Goodman, Judie
    [J]. BLOOD, 2023, 142
  • [46] Hemostasis in pregnant women with COVID-19
    Ciavarella, Alessandro
    Erra, Roberta
    Abbattista, Maria
    Iurlaro, Enrico
    Boscolo-Anzoletti, Massimo
    Ossola, Manuela Wally
    Mosca, Fabio
    Ferrazzi, Enrico
    Peyvandi, Flora
    Martinelli, Ida
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 152 (02) : 268 - 269
  • [47] Pregnant Women and COVID-19 Pandemic
    Arabi, Maliheh
    Teymoordash, Somayyeh Noei
    [J]. TRAUMA MONTHLY, 2021, 26 (01) : 61 - 62
  • [48] COVID-19 in pregnant women reply
    Baud, David
    Giannoni, Eric
    Pomar, Leo
    Qi, Xiaolong
    Nielsen-Saines, Karin
    Musso, Didier
    Favre, Guillaume
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 654 - 654
  • [49] COVID-19 and Impact on Pregnant Women
    Rajnalwar, Deepali
    Chakole, Swaroopa
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (35B) : 55 - 61
  • [50] Managing COVID-19 in pregnant women
    Teelucksingh, Siara
    Nana, Melanie
    Nelson-Piercy, Catherine
    [J]. BREATHE, 2022, 18 (02)